Iovance Biotherapeutics Inc Tangible Net Worth Ratio
Iovance Biotherapeutics Inc tangible net worth ratio. Iovance Biotherapeutics Inc (IOVA) has a Tangible Net Worth Ratio of 59.4% as of September 2025. This metric is calculated by deducting intangible assets ($285.21 Million) from net assets ($702.29 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check IOVA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Iovance Biotherapeutics Inc (2008–2024)
Tangible net worth ratio of Iovance Biotherapeutics Inc from 2008 to 2024. This chart shows how Iovance Biotherapeutics Inc's Tangible Net Worth Ratio has changed across 14 annual periods from 2008 to 2024. As of September 2025, the ratio stands at 59.4%, reflecting net assets of $702.29 Million with intangible assets of $285.21 Million USD. See how liquid is Iovance Biotherapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Iovance Biotherapeutics Inc Tangible Net Worth Ratio by Year (2008–2024)
Iovance Biotherapeutics Inc tangible net worth ratio by year from 2008 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Iovance Biotherapeutics Inc from 2008 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see IOVA company net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 60.2% | $710.40 Million | $282.40 Million | $910.43 Million | ▼ -0.5 pp |
| 2023 | 60.8% | $584.61 Million | $229.26 Million | $780.35 Million | ▼ -39.2 pp |
| 2022 | 100.0% | $499.64 Million | $0.00 | $663.98 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $621.66 Million | $0.00 | $777.33 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $656.50 Million | $0.00 | $768.46 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $298.97 Million | $0.00 | $344.65 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $466.19 Million | $0.00 | $480.82 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $145.48 Million | $0.00 | $155.37 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $166.92 Million | $0.00 | $171.89 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $104.02 Million | $0.00 | $105.65 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $44.85 Million | $0.00 | $46.51 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $17.60 Million | $0.00 | $19.87 Million | ▲ +25.1 pp |
| 2010 | 74.9% | $638.09K | $160.04K | $1.46 Million | ▼ -25.1 pp |
| 2008 | 100.0% | $2.28K | $0.00 | $5.61K | — |